[Stem cell therapy for chronic cardiac insufficiency--therapy of the future?]

W M Franz1, H D Theiss, G Steinbeck

  • 1Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Grosshadern. wolfgang.franz@med.uni-muenchen.de

MMW Fortschritte Der Medizin
|September 27, 2005
PubMed

Insights

Chronic cardiac insufficiency is rising, with limited treatments. Embryonic stem cells offer a promising future therapy, potentially regenerating heart muscle tissue through tissue engineering for transplantation.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biotechnology

Background:

  • The increasing incidence of chronic cardiac insufficiency presents a significant clinical challenge.
  • Current therapeutic options for end-stage heart failure are limited by donor organ scarcity.
  • Stem cell therapy is emerging as a potential future treatment strategy.

Purpose of the Study:

  • To explore the potential of embryonic stem cells (ESCs) in treating chronic cardiac insufficiency.
  • To investigate the feasibility of using tissue engineering with ESCs to generate functional myocardium.
  • To address the limitations of current therapies for end-stage heart failure.

Main Methods:

  • Utilizing the pluripotent nature of embryonic stem cells for potential cardiac tissue regeneration.
  • Employing tissue engineering techniques to develop transplantable myocardial tissue.
  • Evaluating the theoretical capacity of ESCs for indefinite proliferation in cell culture.

Main Results:

  • Embryonic stem cells are pluripotent and capable of indefinite division in vitro.
  • Tissue engineering holds the potential to generate new myocardium from ESCs.
  • This approach could theoretically support pump function in patients with chronic cardiac insufficiency.

Conclusions:

  • Embryonic stem cells represent a significant therapeutic option for chronic cardiac insufficiency.
  • Tissue engineering with ESCs offers a potential solution to the donor organ shortage.
  • Further research is needed to verify the clinical efficacy of ESC-based therapies for chronic heart failure.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.